Readers' Picks: TheStreet.com's Top 10 - TheStreet

Readers' Picks: TheStreet.com's Top 10

Adam Feuerstein reports on hot gene-drug stocks, and James Altucher finds stocks with big buyback programs.
Author:
Publish date:

In case you missed them, here are the 10 most widely read articles and widely viewed videos on TheStreet.com for the past two days (as of July 12). Adam Feuerstein reports on hot gene-drug stocks, and James Altucher finds stocks with big buyback programs.

1.

Top George Soros Stocks With Insider Buying

by James Altucher, published July 11 at 5:52 a.m. EDT.

The list includes Bon-Ton stores and Gen-Probe.

2.

Top 10 Stocks With Big Insider Buying, Buybacks

by James Altucher, published July 12 at 6:24 a.m. EDT.

Repurchases propel Schwab and Tektronix onto this week's list.

3.

You Ask, Cramer Answers

by Stockpickr Staff, published July 12 at 10:46 a.m. EDT.

Jim Cramer answers questions on Newmont Mining, Chindex and more.

4.

Iffy iPhone Call Spurs Analyst Catfight

by Marek Fuchs, published July 11 at 2:49 p.m. EDT.

A cheaper iPhone? An analyst sparked headlines -- and criticism from a peer.

5.

Picture Looks Brighter for Corning

by Scott Moritz, published July 12 at 6:02 a.m. EDT.

The stock rallies as the glassmaker sidesteps a TV screen price war.

6.

Taser Still Has Zing, but Take It Down a Notch

by Frank Curzio, published July 11 at 10:35 a.m. EDT.

Cut your exposure to the maker of nonlethal weapons.

7.

Thursday's Analysts' Upgrades and Downgrades

by TSC Staff, published July 12 at 10:25 a.m. EDT.

Who made what calls.

8.

These Gene-Drug Stocks Are Getting Hot

by Adam Feuerstein, published July 12 at 6:14 a.m. EDT.

A Nobel Prize has stoked the fire in a hot biotech sector.

9.

Three Stocks to Survive a Volatile Second Half

by Jim Jubak, published July 11 at 10:52 a.m. EDT.

More bumps lie ahead, and these three names could benefit.

10.

Cramer: Why NYSE Euronext Earned Its Upgrade

by Jim Cramer and Farnoosh Torabi, published July 11 at 1:25 p.m. EDT.

Jim gives you the scoop on Lehman's recent upgrade of NYSE Euronext.

David Morrow is editor-in-chief of TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.